1. Home
  2. IPWR vs IGC Comparison

IPWR vs IGC Comparison

Compare IPWR & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ideal Power Inc.

IPWR

Ideal Power Inc.

HOLD

Current Price

$3.34

Market Cap

26.3M

Sector

Industrials

ML Signal

HOLD

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

HOLD

Current Price

$0.29

Market Cap

31.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPWR
IGC
Founded
2007
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.3M
31.2M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
IPWR
IGC
Price
$3.34
$0.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$10.75
$4.13
AVG Volume (30 Days)
76.8K
979.4K
Earning Date
11-13-2025
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,136.00
$1,106,000.00
Revenue This Year
N/A
$3.54
Revenue Next Year
$3,233.33
$15.12
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.76
$0.25
52 Week High
$8.62
$0.50

Technical Indicators

Market Signals
Indicator
IPWR
IGC
Relative Strength Index (RSI) 43.69 36.93
Support Level $2.76 $0.28
Resistance Level $3.36 $0.31
Average True Range (ATR) 0.31 0.02
MACD 0.00 -0.00
Stochastic Oscillator 31.58 15.76

Price Performance

Historical Comparison
IPWR
IGC

About IPWR Ideal Power Inc.

Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: